A new era: artificial intelligence and machine learning in prostate cancer

SL Goldenberg, G Nir, SE Salcudean - Nature Reviews Urology, 2019 - nature.com
Artificial intelligence (AI)—the ability of a machine to perform cognitive tasks to achieve a
particular goal based on provided data—is revolutionizing and reshaping our health-care …

The promising role of new molecular biomarkers in prostate cancer: From coding and non-coding genes to artificial intelligence approaches

AP Alarcón-Zendejas, A Scavuzzo… - Prostate cancer and …, 2022 - nature.com
Background Risk stratification or progression in prostate cancer is performed with the
support of clinical-pathological data such as the sum of the Gleason score and serum levels …

Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology

JL Mohler, ES Antonarakis, AJ Armstrong… - Journal of the National …, 2019 - jnccn.org
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis,
risk stratification and workup, treatment options for localized disease, and management of …

Prostate cancer, version 1.2016

JL Mohler, AJ Armstrong, RR Bahnson… - Journal of the National …, 2016 - jnccn.org
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an
initial diagnosis of prostate cancer and management options for localized, regional, and …

FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes

EJ Adams, WR Karthaus, E Hoover, D Liu, A Gruet… - Nature, 2019 - nature.com
Mutations in the transcription factor FOXA1 define a unique subset of prostate cancers but
the functional consequences of these mutations and whether they confer gain or loss of …

The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer

D Chakravarty, A Sboner, SS Nair… - Nature …, 2014 - nature.com
The androgen receptor (AR) plays a central role in establishing an oncogenic cascade that
drives prostate cancer progression. Some prostate cancers escape androgen dependence …

Validation of a 22-gene genomic classifier in patients with recurrent prostate cancer: an ancillary study of the NRG/RTOG 9601 randomized clinical trial

FY Feng, HC Huang, DE Spratt, SG Zhao… - JAMA …, 2021 - jamanetwork.com
Importance Decipher (Decipher Biosciences Inc) is a genomic classifier (GC) developed to
estimate the risk of distant metastasis (DM) after radical prostatectomy (RP) in patients with …

The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex

JR Prensner, MK Iyer, A Sahu, IA Asangani, Q Cao… - Nature …, 2013 - nature.com
Prostate cancers remain indolent in the majority of individuals but behave aggressively in a
minority,. The molecular basis for this clinical heterogeneity remains incompletely …

Artificial intelligence and machine learning in prostate cancer patient management—current trends and future perspectives

OS Tătaru, MD Vartolomei, JJ Rassweiler, O Virgil… - Diagnostics, 2021 - mdpi.com
Artificial intelligence (AI) is the field of computer science that aims to build smart devices
performing tasks that currently require human intelligence. Through machine learning (ML) …

The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer

N Singh, VR Ramnarine, JH Song, R Pandey… - Nature …, 2021 - nature.com
Neuroendocrine (NE) prostate cancer (NEPC) is a lethal subtype of castration-resistant
prostate cancer (PCa) arising either de novo or from transdifferentiated prostate …